To this end, we were aided by a recent study from others demonstrating that ARHGAP35 mutations are found in a subset of lung adenocarcinomas lacking oncogenic driver mutations in the RTK–RAS–ERK pathway [4]. Here, ARHGAP35 is linked to lung adenocarcinoma.